Products
- Anti-Obesity Compound Library
- GPCR/G Protein-Targeted Compounds
- Immunology/Inflammation-Targeted Compounds
- JAK/STAT-Targeted Compounds
- MAPK-Targeted Compounds
- Membrane Transporter/Ion Channel-Targeted Compounds
- Metabolism-Targeted Compounds
- NF-κB-Targeted Compounds
- Microbiology/Virology-Targeted Compounds
- Neuronal Signaling-Targeted Compounds
- PI3K/Akt/mTOR-Targeted Compounds
- Oxidation-reduction-Targeted Compounds
- Proteases/Proteasome-Targeted Compounds
- Stem Cells/Wnt-Targeted Compounds
- Tyrosine Kinase/Adaptors-Targeted Compounds
- Ubiquitin-Targeted Compounds
Online Inquiry
BVT 2733
Cat. No.:
OB0425LY-249
Appearance:
Solid
Purity:
99.72%
Identity:
Confirmed by LC-MS.
Size:
Add to basket
Product Overview
Description:
BVT 2733 is a selective non-steroidal 11β-hydroxydehydrogenase 1 (11β-HSD1) inhibitor.
Synonyms:
376640-41-4; BVT-2733; 3-Chloro-2-methyl-N-(4-(2-(4-methylpiperazin-1-yl)-2-oxoethyl)thiazol-2-yl)benzenesulfonamide; BVT2733; Piperazine, 1-((2-(((3-chloro-2-methylphenyl)sulfonyl)amino)-4-thiazolyl)acetyl)-4-methyl-; Benzenesulfonamide, 3-chloro-2-methyl-N-(4-(2-(4-methyl-1-piperazinyl)-2-oxoethyl)-2-thiazolyl)-; 3-Chloro-2-methyl-N-[4-[2-(4-methylpiperazin-1-yl)-2-oxoethyl]-1,3-thiazol-2-yl]benzenesulfonamide
CAS No.:
376640-41-4
Compound CID:
6918651
Formula:
C17H21ClN4O3S2
Formula Weight:
428.96
Specification
Target:
11β-HSD
Pathway:
Metabolic enzyme/Protease
Solubility:
DMSO
Storage:
Storage at -20°C.
Applications:
BVT 2733 can be used to study metabolic syndrome, hyperglycemia and insulin resistance associated with type 2 diabetes, and to investigate its potential to improve glucose-lipid metabolism and cardiovascular health.
